We therefore addressed this issue in the current study and analyzed 38 PTPs in a cohort of 66 newly diagnosed CML patients treated with nilotinib (TIGER study). The gene discussed is PTS; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.